We are live on ! Find out more
ENZ

Enzo Biochem, Inc.

Delisted

ENZ was delisted on the 17th of April, 2025.

Fund managers haven’t disclosed any holdings of ENZ yet.

ENZ Hedge Fund Activity: Q3 2025 in Review

0 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q3 2025, worth a combined $0 — down 100% from $254K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ENZ and 0 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was RBF Capital, exiting entirely with an estimated $102K sold.

  • 0 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q3 2025, down from 6 in Q2 2025.
  • Funds reported $0 of Enzo Biochem, Inc. stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Enzo Biochem, Inc. positions in Q3 2025 and 6 closed out, a net change of -6 holders.
  • The largest Enzo Biochem, Inc. seller in Q3 2025 was RBF Capital, an estimated $102K sold.

Based on aggregated 13F filings for Q3 2025.